Search for: "Boehringer Ingelheim Pharmaceutical, Inc" Results 41 - 60 of 90
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
25 Jan 2014, 9:43 am by Barry Barnett
In re Petition of Boehringer Ingelheim Pharmaceuticals, Inc., No. 13-3898 (7th Cir. [read post]
7 Dec 2010, 2:43 am by Ben Vernia
As for Roxane: Roxane is paying $280 million to resolve claims against it and related entities (Roxane Laboratories Inc., Boehringer Ingelheim Corp. and Boehringer Ingelheim Pharmaceuticals Inc.). [read post]
28 Jan 2014, 11:53 am
  In re Petition of Boehringer Ingelheim Pharmaceuticals, Inc., and Boehringer Ingelheim Int’l. [read post]
6 Apr 2009, 8:20 am
" Among those companies ordered "to stop using the ads" were "Merck & Co., Roche Holding AG, Bayer AG, Johnson & Johnson, Forest Laboratories Inc., Eli Lilly & Co., Boehringer Ingelheim GmbH, Genentech Inc., GlaxoSmithKline Plc and Novartis AG. [read post]
2 May 2012, 11:11 am
According to the complaint, Boehringer Ingelheim Pharmaceuticals, Inc. concealed knowledge that Pradaxa can cause serious, life-threatening bleeds, and did not warn that Pradaxa bleeding side effects may be irreversible. [read post]
24 Apr 2014, 8:34 am by AmericanConferenceInstitute
Companies confirmed to speak to date include: Asuragen ■ Amgen ■ Avanir Pharmaceuticals ■ Bayer ■ Biocryst Pharmaceuticals ■ Biogen Idec ■ Blueprint Medicines ■ Covidien ■ Edwards Lifesciences ■ Eisai Inc ■ Endo Pharmaceuticals ■ Ipsen… [read post]
22 Aug 2016, 1:05 pm by jromDLT
You may be entitled to compensation for your medical bills, lost wages, pain and suffering and other damages that can be pursued in a defective drug lawsuit against the manufacturer of Pradaxa, Boehringer Ingelheim Pharmaceuticals, Inc. [read post]
20 Aug 2012, 2:01 pm by Brenda Fulmer
These Pradaxa lawsuits were filed against Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim Corporation, Boehringer Ingelheim USA Corporation, and Boehringer Ingelheim Vetmedica, Inc.  [read post]
29 Dec 2009, 9:09 pm by ipdeals
Director Team Leader, International Business Development, Pfizer Bill Bertrand, Senior Vice President, Legal Affairs, General Counsel and Corporate Compliance Officer, MedImmune Adelene Perkins, President and Chief Business Officer, Infinity Pharmaceuticals Michael Leonetti; Head, Health Care Partnerships, Boehringer Ingelheim David Low, Managing Director, Lazard Sanj Singh, CEO, Ade Therapuetics Here is a link to the event where you can get more… [read post]
9 Dec 2010, 2:49 am by Bob Kraft
Specifically, “Boehringer Ingelheim GmbH’s Roxane Inc. will pay $280 million, Abbott will pay $126.5 million and B. [read post]
9 Dec 2010, 3:53 am by Bob Kraft
Specifically, "Boehringer Ingelheim GmbH's Roxane Inc. will pay $280 million, Abbott will pay $126.5 million and B. [read post]
3 Dec 2009, 10:16 pm
Supporters can click the Make it Happen link and send an email to the CEOs of Abbott Laboratories, Boehringer Ingelheim, Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline, Johnson & Johnson, Merck & Co, Pfizer Inc. and Sequoia Pharmaceuticals Inc. [read post]
30 Jan 2020, 5:29 am by Brenda Fulmer
The Zantac litigation effort involves several international drug companies, including Boehringer Ingelheim Pharmaceuticals (based in Connecticut); Boehringer Ingelheim Corporation (German parent company); Sanofi US Services, Inc. [read post]
30 Jan 2020, 5:29 am by Brenda Fulmer
The Zantac litigation effort involves several international drug companies, including Boehringer Ingelheim Pharmaceuticals (based in Connecticut); Boehringer Ingelheim Corporation (German parent company); Sanofi US Services, Inc. [read post]